Why the study?
Delayed treatment and inadequate early detection may deteriorate the quality of life in individuals experiencing cardiovascular symptoms following long COVID.
This review highlights the cardiovascular manifestations of long COVID and emphasizes the need for early detection and comprehensive management to prevent deterioration of patients' quality of life.
Answers are grounded in this paper and cite their sources.
Cardiovascular symptoms in long COVID warrant clinical vigilance; leaves open optimal management strategies.
Even after nasopharyngeal Polymerase Chain Reaction (PCR) swab investigation revealed no COVID-19 infection, some individuals continue to have long COVID symptoms. According to a research published in 2022, 4.5 – 36.6% of patients had symptoms following a COVID-19 infection more than three months. Long COVID symptoms may impact multiple organ systems, including the cardiovascular system. Chest pain, palpitations, arrhythmia, postural orthostatic tachycardia syndrome, and other symptoms are possible appeared in long COVID. D-Dimer, echocardiography, CT scan, cMRI and other supportive test showed meaningful results. Pharmacological treatment can be given based on the concurrent diagnosis found in patients with long COVID. While non-pharmacological treatment can be given in the form of pulmonary rehabilitation, breathing exercises, acupuncture, and COVID-19 vaccination. The state and quality of life of individuals experiencing cardiovascular symptoms following a long COVID infection may deteriorate due to delayed treatment and inadequate early detection.
No takes yet. Share an insight, caveat, or question.
A 2024 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: